CHEMGENEX PHARMACEUTICALS LTD has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and Japan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NIPPON SHINYAKU CO LTD, BIOMARIN PHARM INC and INST PHARM & TOXICOLOGY AMMS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Japan | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Brown Dennis M | 5 |
#2 | Robin Jean-Pierre | 3 |
#3 | Blanchard Julie | 2 |
#4 | Maisonneuve Herve | 2 |
#5 | Maloisel Frederick | 2 |
#6 | Collier Gregory Royce | 2 |
#7 | Segal David S | 2 |
#8 | Mahon Francois-Xavier | 2 |
#9 | Dujardin Gilles | 1 |
#10 | Nicholson Geoffrey Charles | 1 |
Publication | Filing date | Title |
---|---|---|
WO2006029462A1 | A nucleic acid molecule differentially expressed in a mouse behavioural model system and uses thereof | |
WO2006024096A1 | Method for modulating osteoclastogenesis | |
WO2005003351A1 | Differential expression of nucleic acid molecules | |
CA2491673A1 | Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |